# Evaluating Blast-X® in Combination With Negative Pressure Wound Therapy

> **NCT04265170** · NA · COMPLETED · sponsor: **SerenaGroup, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Pressure Ulcer

## Interventions

- **DEVICE:** BlastX with negative pressure therapy

## Key facts

- **NCT ID:** NCT04265170
- **Lead sponsor:** SerenaGroup, Inc.
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-24
- **Primary completion:** 2021-07-31
- **Final completion:** 2022-02-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04265170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04265170, "Evaluating Blast-X® in Combination With Negative Pressure Wound Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04265170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*